investigator-initiated studies: two stories from the nih
DESCRIPTION
Late Phase Study Planning and Budgeting - Michael Lauer January 11, 2012TRANSCRIPT
Investigator-Initiated Studies:Two Stories from the NIH
Michael S Lauer, MD, FACC, FAHADirector, Division of Cardiovascular Sciences
NHLBI/NIHJanuary 11, 2012
Disclosures: None
First Story: Occluded Artery after MI
2http://www.circulation.or.kr/info/case/200904/fig1.gif http://www.indiastudychannel.com/attachments/Resources/82666-221135-Coronary%20Angiogram.jpg
Observational Findings
3 Lamas GA et al. Circulation 1995;92:1101-9
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
9/30/99OAT Starts
6/15/98-8/02/99OAT Pilot enrollment
12/30/05OAT Recruitment
CompletedTotal: 2166
07/2001TOSCA-2
begins
08/2002OAT-EP begins
12/2003OAT-NUC
begins
AHA
6/1/19981st NHLBI submission
3/1/19992nd NHLBI submission
NHLBI Workshop on Coronary
Revascularization
1st OAT Steering
Committee
151 409 485 523 382 196
Enrolled patients per year
20
OAT Timeline
Many thanks to Dr. Judith Hochman
Investigator-Cited Problems
Funding Slow to obtain, pilot work unfunded Inadequate once there Private partnerships difficult
Sites Only 320 of 925 agreed (pro-PCI bias) Only 217 of 320 enrolled at least 1 patient Rate 0.25 patients/site/month Only 488 patients from 85 US sites
5 Many thanks to Dr. Judith Hochman
More Problems
Regulatory burdens IRB redundancies and requirements Site monitoring, HIPAA
Bias against withholding available treatment Physicians (91% of refusals)
Strongly held beliefs Loss of procedural revenues
Patients (want the best technology)
6 Many thanks to Dr. Judith Hochman
Physician Bias and “Ethics”
When researchers tried to organize a randomized study of the benefits of angioplasty for patients who had suffered a heart attack three days or more before, they ran into a problem. Many doctors were so convinced of the value of this procedure…that they thought it would be unethical to assign any patients to the control group, which would get all the best medicines for this condition but not the artery-reopening procedure.
But the researchers persisted, with heavy support from the National Heart, Lung, and Blood Institute. After four years of work examining 2,166 patients, they came to an unexpected conclusion….
7 Boston Globe, December 9, 2006
The Findings and Response
8
ACC/AHA STEMI Guideline: “PCI of a totally occluded infarct artery greater than 24 hours after STEMI is not recommended in asymptomatic patients…[who] do not have evidence of severe ischemia.”
Hochman JS. N Engl J Med 2006;355:2395-407Antman EM et al. JACC 2008;51:210-47
A More Recent Story
9Ridker PM. J Throm Haemost 2009;7(S 1):332-9Ridker PM et al. N Engl J Med 2008;359:2195-207
The Proposal
2008: “LAP” process
2009-2010: Grant reviews
Early - mid 2011: Council Revision (not a CRP
trial), funding
10 Ridker PM. J Throm Haemost 2009;7(S 1):332-9
Insights from These Stories
Government-funded trials Encourage investigator-initiated studies Extensive vetting process prior to review Effectiveness and efficacy
Challenges Lengthy process Resistant clinical community Manage conflicts of interest Responsible delivery of “public goods”
11